| 引用本文：张平,徐怀伏.药店在政府激励性管制下的战略选择——基本药物制度的视角[J].中国卫生政策研究,2010,3(1):54-57 |
|
| 药店在政府激励性管制下的战略选择——基本药物制度的视角 |
| 投稿时间：2009-11-16 修订日期：2009-11-23 PDF全文浏览 HTML全文浏览 |
| 张平, 徐怀伏 |
| 中国药科大学国际医药商学院 |
| 摘要:2009年8月18日，307种药物进入基本药物目录，这是政府在推进基本药物制度坚实有力的一步。药品零售市场是一个极具潜力的市场，但由于有医保定点药店的存在，中国的药品零售市场是一个相对较弱的垄断市场。基本药物制度是政府在推进新医改过程中的激励性管制，有利于整合药品零售市场的资源，增加了药店经营的自主性，但是在价格和进入机制方面设立了障碍。在这种政府激励性管制的形势下，药店在经营过程中应该从多元化、更加注重药学服务和与社区医疗和上游的处方药供应商建立良好的关系等方面做出自己的战略选择 |
| 关键词:基本药物制度 药品零售 激励性管制 战略选择 |
|
| The strategy choice of pharmacy under the government of incentive regulation: the view of essential medicines system |
| ZHANG Ping, ZHANG Huai-fu |
| School of International Pharmaceutical Business, China Pharmacy University |
| Abstract:On August 18, 2009，there were 307 kinds of drugs in the essential medicines catalog, which is a firm step of the government to promote the essential medicines system. The drug retail market is of great potency, but due to the existence of health insurance designated pharmacies, it is a weak monopoly market. The basic pharmaceuticals system is the incentive regulation in the process of new health system reform, which is good for integrating the resources of medicine retail market and increasing the autonomy of pharmacy business, but it provided obstacles in terms of price and access mechanism. Under the situation of incentive regulation by the government, the retail pharmacies should pay more attention to make their own strategy choice in terms of the diversification and pharmaceutical care, a good relationship with community health facilities, and with prescription drugs suppliers. |
| Key words:Essential medicines system Retail of medicine Incentive regulation Strategy choice |
| 摘要点击次数: 3322 全文下载次数: 3641 |
|
|
